Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of human dental pulp mesenchymal stem cell injection for chronic periodontitis
CTR20231508Phase 2Active
- Sponsor
- Sanyouli Heze
- Start
- Nov 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human dental pulp mesenchymal stem cells in chronic periodontitis, sponsored by Sanyouli Heze. Started Nov 2023; status: active.
02
Drugs
human dental pulp mesenchymal stem cells
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on CTR20231508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231508.